Literature DB >> 17185905

A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule.

H J L M Timmers1, E M van Ginneken, P Wesseling, C G J Sweep, A R M M Hermus.   

Abstract

A 41-yr-old female was referred for signs and symptoms of Cushing's syndrome. Cortisol was not suppressed by 1 mg dexamethasone (0.41 micromol/l). Midnight cortisol and ACTH were 0.44 micromol/l and 18 pmol/l, respectively. Urinary cortisol excretion was 250 nmol/24 h (normal between 30 and 150 nmol/24 h). A magnetic resonance imaging (MRI) revealed a pituitary lesion of 7 mm. ACTH and cortisol levels were unaltered by administration of human CRH and high-dose dexamethasone. Inferior sinus petrosus sampling showed CRH-stimulated ACTH levels of 128.4 (left sinus) vs a peripheral level of 19.2 pmol/l, indicating Cushing's disease. After 4 months of pre-treatment with metyrapone and dexamethasone, endoscopic transsphenoidal resection of an ACTH-positive pituitary adenoma was performed. ACTH levels decreased to 2.6 pmol/l and fasting cortisol was 0.35 micromol/l. Despite clinical regression of Cushing's syndrome and normalization of urinary cortisol, cortisol was not suppressed by 1 mg dexamethasone (0.30 micromol/l). Ten months post-operatively, signs and symptoms of Cushing's syndrome reoccurred. A high dose dexamethasone test according to Liddle resulted in undetectable ACTH, but no suppression of cortisol levels, pointing towards adrenal-dependent Cushing's syndrome. Computed tomography (CT)-scanning showed a left-sided adrenal macronodule. Laparoscopic left adrenalectomy revealed a cortical macronodule (3.5 cm) surrounded by micronodular hyperplasia. Fasting cortisol had decreased to 0.02 micromol/l. Glucocorticoid suppletion was started and tapered over 12 months. Symptoms and signs of hypercortisolism gradually disappeared. This case illustrates, that longstanding ACTH stimulation by a pituitary adenoma can induce unilateral macronodular adrenal hyperplasia with autonomous cortisol production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17185905     DOI: 10.1007/BF03349200

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Coexistence of unilateral adrenal macronodule and Cushing's disease. Report of two cases.

Authors:  G Borretta; M Terzolo; F Cesario; I Meineri; A Pia; A Angeli
Journal:  J Endocrinol Invest       Date:  1996-02       Impact factor: 4.256

2.  Cushing's disease coexisting with a single macronodule simulating adenoma of the adrenal cortex.

Authors:  S Leiba; B Shindel; I Weinberger; J Fuchs; Z Rotenberg; C Mor; H Kaufman
Journal:  Acta Endocrinol (Copenh)       Date:  1986-07

3.  Transition from pituitary-dependent to adrenal-dependent Cushing's syndrome.

Authors:  A R Hermus; G F Pieters; A G Smals; G J Pesman; S W Lamberts; T J Benraad; U J van Haelst; P W Kloppenborg
Journal:  N Engl J Med       Date:  1988-04-14       Impact factor: 91.245

4.  Coexistence of pituitary adrenocorticotropin-dependent Cushing's syndrome with a solitary adrenal adenoma.

Authors:  D E Schteingart; H S Tsao
Journal:  J Clin Endocrinol Metab       Date:  1980-05       Impact factor: 5.958

5.  Cushing's syndrome presenting the coexistence of a pituitary corticotrophic cell hyperplasia and a unilateral functional adrenal adenoma.

Authors:  H Watanobe; T Kawagishi; Y Hirai; T Sato; M Tsutsui; Y Kamata; K Takebe
Journal:  Acta Endocrinol (Copenh)       Date:  1985-11

6.  Continuous dexamethasone infusion for seven hours in patients with the Cushing syndrome. A superior differential diagnostic test.

Authors:  P Biemond; F H de Jong; S W Lamberts
Journal:  Ann Intern Med       Date:  1990-05-15       Impact factor: 25.391

7.  The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers.

Authors:  M A MacKenzie; W H Hoefnagels; R W Jansen; T J Benraad; P W Kloppenborg
Journal:  J Clin Endocrinol Metab       Date:  1990-06       Impact factor: 5.958

8.  Different sensitivity to adrenocorticotropin of dispersed adrenocortical cells from patients with Cushing's disease with macronodular and diffuse adrenal hyperplasia.

Authors:  S W Lamberts; E G Bons; H A Bruining
Journal:  J Clin Endocrinol Metab       Date:  1984-06       Impact factor: 5.958

9.  Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome.

Authors:  E H Oldfield; J L Doppman; L K Nieman; G P Chrousos; D L Miller; D A Katz; G B Cutler; D L Loriaux
Journal:  N Engl J Med       Date:  1991-09-26       Impact factor: 91.245

10.  Pituitary ACTH dependency of nodular adrenal hyperplasia in Cushing's syndrome. Report of two cases and review of the literature.

Authors:  D C Aron; J W Findling; P A Fitzgerald; R M Brooks; F E Fisher; P H Forsham; J B Tyrrell
Journal:  Am J Med       Date:  1981-08       Impact factor: 4.965

View more
  3 in total

1.  Adrenal nodules in patients with Cushing's disease: prevalence, clinical significance and follow-up.

Authors:  N M Albiger; G Occhi; F Sanguin; M Iacobone; G Casarrubea; S Ferasin; F Mantero; C Scaroni
Journal:  J Endocrinol Invest       Date:  2010-11-16       Impact factor: 4.256

2.  Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic CTNNB1, USP8, and NR3C1 Mutations.

Authors:  Mario Detomas; Barbara Altieri; Wiebke Schlötelburg; Silke Appenzeller; Sven Schlaffer; Roland Coras; Andreas Schirbel; Vanessa Wild; Matthias Kroiss; Silviu Sbiera; Martin Fassnacht; Timo Deutschbein
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-20       Impact factor: 5.555

Review 3.  Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge.

Authors:  José Miguel Hinojosa-Amaya; Elena V Varlamov; Shirley McCartney; Maria Fleseriu
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-08       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.